Halogenated xanthene

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Intracorporeal medicaments for photodynamic treatment of disease
US 7390668 B2Applicant: PROVECTUS PHARMATECH INCPriority: 2000
CN
EP
US
WO
12 publications
A COMBINATION OF ROSE BENGAL AND ANTI-CTLA4 ANTIBODY FOR USE IN THE TREATMENT OF CANCER
EP 2710137 B1Applicant: PROVECTUS PHARMATECH INCPriority: 2011
CN
EP
US
WO
12 publications
TREATMENT OF SOLID CANCEROUS TUMORS BY ORAL ADMINISTRATION OF A HALOGENATED XANTHENE
EP 4106814 A4Applicant: PROVECTUS PHARMATECH INCPriority: 2020
CN
EP
US
WO
12 publications
IN VITRO AND XENOGRAFT ANTI-TUMOR ACTIVITY OF A HALOGENATED-XANTHENE AGAINST REFRACTORY PEDIATRIC SOLID TUMORS
EP 3773548 B1Applicant: PROVECTUS PHARMATECH INCPriority: 2018
CN
EP
US
WO
9 publications
INTRACORPOREAL MEDICAMENTS FOR HIGH ENERGY PHOTOTHERAPEUTIC TREATMENT OF DISEASE
- EP 1292298 B1
  Applicant: PHOTOGEN INCPriority: 2000
  EP
  US
  WO
  6 publications
- US 8470296 B2
  Applicant: DEES H CRAIGPriority: 2007
  US
  2 publications
- US 2010076246 A1
  Applicant: PROVECTUS PHARMATECH INCPriority: 2009
  US
COMBINATION OF LOCAL AND SYSTEMIC THERAPIES FOR ENHANCED TREATMENT OF DERMATOLOGIC CONDITIONS
EP 3700520 C0Applicant: UNIV ROCKEFELLERPriority: 2017
CN
EP
US
WO
5 publications
IMPROVED TOPICAL MEDICAMENTS AND METHODS FOR PHOTODYNAMIC TREATMENT OF DISEASE
EP 1210078 B1Applicant: PROVECTUS PHARMATECH INCPriority: 1999
CN
EP
WO
5 publications
Medicaments for chemotherapeutic treatment of disease
- US 7648695 B2
  Applicant: PROVECTUS PHARMATECH INCPriority: 2000
  EP
  US
  WO
  5 publications
- US 2008118567 A1
  Applicant: PROVECTUS PHARMATECH INCPriority: 2007
  US
  2 publications
METHOD OF EX VIVO ENHANCEMENT OF IMMUNE CELL ACTIVITY FOR CANCER IMMUNOTHERAPY WITH A SMALL MOLECULE ABLATIVE COMPOUND
EP 3347041 A1Applicant: PROVECTUS PHARMATECH INCPriority: 2015
EP
US
WO
5 publications
Ultrasound contrast using halogenated xanthenes
US 6986740 B2Applicant: XANTECH PHARMACEUTICALS INCPriority: 2002
EP
US
4 publications

Drugs

Halogenated xanthene

Patents

INTRACORPOREAL MEDICAMENTS FOR HIGH ENERGY PHOTOTHERAPEUTIC TREATMENT OF DISEASE

Medicaments for chemotherapeutic treatment of disease